Skip to main content
SYRE
NASDAQ Life Sciences

Spyre Therapeutics Stock Slides 12% After $350M Offering Priced at $85

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$81.158
Mkt Cap
$7.156B
52W Low
$15.86
52W High
$110.175
52W Position info
412% above low
Off High info
26% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

SYRE has more than doubled off its 52-week low of $15.86 on elevated volume (1.9× avg).

Summary

Spyre Therapeutics priced a $350 million public offering of 4,117,648 shares at $85 per share, a 4.5% discount to the last close. Underwriting discounts are $5.10 per share, with net proceeds of approximately $328.7 million. Underwriters have a 30-day option to purchase up to 617,647 additional shares. The stock fell 12% to $81.83 in midday trading Tuesday, reflecting dilution concerns. Proceeds will fund drug development across gastroenterology, rheumatology, and dermatology. The offering is expected to close Wednesday. This follows positive Phase 2 data for SPY003 in ulcerative colitis announced in September.

Updated with an SEC 424B5 filing · What changed

Updates

  1. · SEC 424B5 — The 424B5 prospectus supplement details the offering: 4,117,648 shares at $85.00, underwriting discounts of $5.10 per share, net proceeds of approximately $328.7 million, and a 30-day underwriters' option for 617,647 additional shares.

At the time of this announcement, SYRE was trading at $81.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $15.86 to $110.18. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

SYRE - Latest Insights

SYRE
Nov 03, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $99.73
Real-time Price: $104.48 info
Change: +$4.75 (+5%) info
Market Cap: $9.922B info
SYRE
Nov 03, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $99.73
Real-time Price: $104.48 info
Change: +$4.75 (+5%) info
Market Cap: $9.922B info
SYRE
Oct 07, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $80.51
Real-time Price: $104.48 info
Change: +$23.97 (+30%) info
Market Cap: $9.922B info
SYRE
Oct 06, 2026, 4:41 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $80.11
Real-time Price: $104.48 info
Change: +$24.37 (+30%) info
Market Cap: $9.922B info
SYRE
Oct 05, 2026, 4:03 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $89.81
Real-time Price: $104.48 info
Change: +$14.67 (+16%) info
Market Cap: $9.922B info